Composition
Each 1 ml contains 25 mg or 50 mg nandrolone laurate.

Pharmacological Classification
C.22.4 Anabolic steroids.

Pharmacological Action
Laurabolin has a powerful and longlasting (3-4 weeks) anabolic effect. As a result of this Laurabolin is capable of building up the protein content of bone and muscle tissue where these are depleted. The androgenic effect of Laurabolin when administered in the prescribed dosage is so small that it may be administered to both male and female animals. Laurabolin has a positive effect on nitrogen, calcium and phosphorus metabolism. In addition Laurabolin has a tonic effect causing an increase in appetite.

Indications
Laurabolin assists in the shortening of convalescent periods after chronic and debilitating diseases. Laurabolin is indicated in all cases where an increased rate of tissue-building is required. The indications per species are given under "Dosage and directions for use".

Contra-indications
Prostatic hyperplasia. Androgen-dependant tumours e.g. anal adenomata and prostate carcinoma. Do not use in breeding or potential breeding stock.

Warnings
Withdrawal Period: Meat 4 weeks.

Side-effects and Special Precautions
The side effects include increased androgenic symptoms and sodium retention. Care should be exercised in the use of these products in old dogs with chronic interstitial nephritis.

Known symptoms of overdosage and particulars of its treatment
The treatment of overdosage is to reduce or terminate dosage and treat symptomatically and supportively. Symptoms include an increase in the masculinising effects and / or sodium and water retention.

Identification
Laurabolin is a clear-off-white oily solution packed in clear glass vials.

Storage Instructions
Store between 20°C and 25°C. Keep out of reach of children and uninformed persons.

Presentation
5 ml and 10 ml multidose vials.

Registration holder
Intervet S.A. (Pty) Ltd
Co. Reg. No. 1991/006580/07